SC
PBYI icon

SouthState Corp’s Puma Biotechnology PBYI Stock Holding History

SouthState Corp’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-111
Closed -$381 – 1535
2025
Q2 		$381 Hold
111
– – ﹤0.01% 1486
2025
Q1 		$329 Buy
+111
New +$347 ﹤0.01% 1607

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

SouthState Corp's PBYI Position: Q3 2025 in Review

SouthState Corp sold out of Puma Biotechnology (PBYI) in Q3 2025, closing a stake of 111 shares — an estimated $381 sold.

SouthState Corp first reported a position in PBYI in Q1 2025 and held it in 2 quarters. The position peaked at $381 in Q2 2025. 132 funds tracked by Wall St. Rank hold PBYI as of Q3 2025.

  • SouthState Corp reported no remaining Puma Biotechnology position as of Q3 2025 after selling out during the quarter.
  • SouthState Corp sold 111 Puma Biotechnology shares in Q3 2025, an estimated $381.
  • SouthState Corp first reported a position in Puma Biotechnology in Q1 2025 and held it in 2 quarters.
  • SouthState Corp's Puma Biotechnology position peaked at $381 in Q2 2025.
  • 132 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2025.

Based on SouthState Corp's 13F filing for Q3 2025, filed 5 Nov 2025.